Unemployment Woes: Recurring Claims Reach a Three-Year Peak in 2024

Unemployment Woes: Recurring Claims Reach a Three-Year Peak in 2024 Continuing Unemployment Benefit Applications on the Rise Continuing unemployment benefit applications are now at their highest in more than three years. Data released Thursday (Dec. 26) by the U.S. Labor Department showed these applications — typically seen as a stand-in

Read More »

Unveiling the Future of Healthcare: Ascentage Pharma to Take the Stage at 43rd Annual JP Morgan Healthcare Conference

Unveiling the Future of Healthcare: Ascentage Pharma to Take the Stage at 43rd Annual JP Morgan Healthcare Conference Breaking Boundaries in Healthcare Innovation ROCKVILLE, Md. and SUZHOU, China , Dec. 26, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address

Read More »

Attention Investors: Important Deadline Approaching for Kyverna Therapeutics Shareholders – Take Action Now!

Attention Investors: Important Deadline Approaching for Kyverna Therapeutics Shareholders – Take Action Now! Introduction Investors, listen up! There is an important deadline approaching for Kyverna Therapeutics shareholders that you need to be aware of. Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C.

Read More »

Uncovering the Truth: Why This Convertible Bond CEF is Grossly Overpriced

Uncovering the Truth: Why This Convertible Bond CEF is Grossly Overpriced Description: The Calamos Convertible Opportunities and Income Fund offers a high 9.38% yield, appealing to income-focused investors despite being lower than the peer median of 10.49%. The fund’s mixed asset strategy, including convertible securities and bonds, provides equity exposure

Read More »